Association between circulating Asprosin levels and carotid atherosclerotic plaque in patients with type 2 diabetes
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Association between circulating Asprosin levels and carotid atherosclerotic plaque in patients with type 2 diabetes
Authors
Keywords
-
Journal
CLINICAL BIOCHEMISTRY
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2022-08-09
DOI
10.1016/j.clinbiochem.2022.04.018
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Adiponectin, Leptin and Cardiovascular Disorders
- (2021) Shangang Zhao et al. CIRCULATION RESEARCH
- High Serum Asprosin Levels Are Associated with Presence of Metabolic Syndrome
- (2021) Tao Hong et al. International Journal of Endocrinology
- The Diabetes Mellitus–Atherosclerosis Connection: The Role of Lipid and Glucose Metabolism and Chronic Inflammation
- (2020) Anastasia Poznyak et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Obesity Phenotypes, Diabetes, and Cardiovascular Diseases
- (2020) Marie-Eve Piché et al. CIRCULATION RESEARCH
- The Asprosin–OLFR734 module regulates appetitive behaviors
- (2020) Yang Liu et al. Cell Discovery
- Serum concentration of asprosin in new-onset type 2 diabetes
- (2020) Shakiba Naiemian et al. Diabetology & Metabolic Syndrome
- Adipokines and Inflammation: Focus on Cardiovascular Diseases
- (2020) Sandra Feijóo-Bandín et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The Role of Ceramides in Diabetes and Cardiovascular Disease Regulation of Ceramides by Adipokines
- (2020) Bianca C. Field et al. Frontiers in Endocrinology
- Resistin: Potential biomarker and therapeutic target in atherosclerosis
- (2020) Li Zhou et al. CLINICA CHIMICA ACTA
- The Adipocyte and Adaptive Immunity
- (2020) Jianfeng Song et al. Frontiers in Immunology
- Saliva and Blood Asprosin Hormone Concentration Associated with Obesity
- (2019) Kader Ugur et al. International Journal of Endocrinology
- Insulin Resistance and Atherosclerosis: Implications for Insulin Sensitizing Agents
- (2019) Antonino Di Pino et al. ENDOCRINE REVIEWS
- Asprosin attenuates insulin signaling pathway through PKCδ‐activated ER stress and inflammation in skeletal muscle
- (2019) Tae Woo Jung et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Asprosin impairs insulin secretion in response to glucose and viability through TLR4/JNK-mediated inflammation
- (2019) Taeseung Lee et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- OLFR734 Mediates Glucose Metabolism as a Receptor of Asprosin
- (2019) Erwei Li et al. Cell Metabolism
- Decreased Circulating Levels of Asprosin in Obese Children
- (2019) Wenjun Long et al. Hormone Research in Paediatrics
- Visceral and ectopic fat, atherosclerosis, and cardiometabolic disease: a position statement
- (2019) Ian J Neeland et al. Lancet Diabetes & Endocrinology
- Asprosin improves the survival of mesenchymal stromal cells in myocardial infarction by inhibiting apoptosis via the activated ERK1/2-SOD2 pathway
- (2019) Zhengbin Zhang et al. LIFE SCIENCES
- Relevance of Leptin and Other Adipokines in Obesity-Associated Cardiovascular Risk
- (2019) Manuel F. Landecho et al. Nutrients
- The Asprosin-OLFR734 hormonal signaling axis modulates male fertility
- (2019) Fangchao Wei et al. Cell Discovery
- A novel biochemical marker for predicting the severity of ACS with unstable angina pectoris: Asprosin
- (2018) Ahmet Cagdas Acara et al. AMERICAN JOURNAL OF EMERGENCY MEDICINE
- IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045
- (2018) N.H. Cho et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Prevalence of micro- and macrovascular diabetes complications at time of type 2 diabetes diagnosis and associated clinical characteristics: A cross-sectional baseline study of 6958 patients in the Danish DD2 cohort
- (2018) Anne Gedebjerg et al. JOURNAL OF DIABETES AND ITS COMPLICATIONS
- Atherosclerosis
- (2018) Kouji Kobiyama et al. CIRCULATION RESEARCH
- Asprosin: a novel peptide hormone related to insulin resistance in women with polycystic ovary syndrome
- (2018) Murat Alan et al. GYNECOLOGICAL ENDOCRINOLOGY
- GW29-e0080 The protective role of Asprosin against diabetes in cardiomyocytes
- (2018) Jian Feng et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Plasma Asprosin Levels Are Associated with Glucose Metabolism, Lipid, and Sex Hormone Profiles in Females with Metabolic-Related Diseases
- (2018) Xing Li et al. MEDIATORS OF INFLAMMATION
- Asprosin is a centrally acting orexigenic hormone
- (2017) Clemens Duerrschmid et al. NATURE MEDICINE
- Asprosin, a Fasting-Induced Glucogenic Protein Hormone
- (2016) Chase Romere et al. CELL
- FBN1 : The disease-causing gene for Marfan syndrome and other genetic disorders
- (2016) Lynn Y. Sakai et al. GENE
- Adipokines in health and disease
- (2015) Mathias Fasshauer et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Adipokines as mediators of endothelial function and atherosclerosis
- (2013) George Ntaios et al. ATHEROSCLEROSIS
- Adipokines: A link between obesity and cardiovascular disease
- (2013) Kazuto Nakamura et al. Journal of Cardiology
- Nationwide Study on Trends in Hospital Admissions for Major Cardiovascular Events and Procedures Among People With and Without Diabetes in England, 2004-2009
- (2011) E. P. Vamos et al. DIABETES CARE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More